Skip to Main Content
TABLE 1

Patient Characteristics

Value
Age, median (range) 11 y (2 mo to 23 y) 
Sex (N = 50), % of total  
 Male 56 
 Female 44 
Diagnosis (N = 50), % of total  
 Cancer 80 
  Leukemia 26 
  CNS tumor 14 
  Solid tumor 40 
 Cystic fibrosis 
 Seizure disorder 
 Other 
Reason for use or potential use (>1 possible per patient), % of total  
 Nausea and vomiting 40 
 Appetite stimulation 36 
 Pain 38 
 Seizures 
 Anticancer 20 
 Other 14 
Product used (N = 50), % of total  
 Tetrahydrocannabinol only 
 Cannabidiol only 20 
 Tetrahydrocannabinol and cannabidiol combination 12 
 No product at time of consultation 62 
Value
Age, median (range) 11 y (2 mo to 23 y) 
Sex (N = 50), % of total  
 Male 56 
 Female 44 
Diagnosis (N = 50), % of total  
 Cancer 80 
  Leukemia 26 
  CNS tumor 14 
  Solid tumor 40 
 Cystic fibrosis 
 Seizure disorder 
 Other 
Reason for use or potential use (>1 possible per patient), % of total  
 Nausea and vomiting 40 
 Appetite stimulation 36 
 Pain 38 
 Seizures 
 Anticancer 20 
 Other 14 
Product used (N = 50), % of total  
 Tetrahydrocannabinol only 
 Cannabidiol only 20 
 Tetrahydrocannabinol and cannabidiol combination 12 
 No product at time of consultation 62 

CNS, central nervous system.

Close Modal

or Create an Account

Close Modal
Close Modal